[Molecular and pharmacological bases of antineoplastic chemotherapy].
D000477:Alkylating Agents / Q000138:chemical synthesis; D000900:Anti-Bacterial Agents / Q000096:biosynthesis; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D001215:Asparaginase / Q000008:administration & dosage; D003248:Constipation / Q000139:chemically induced; D004247:DNA / Q000096:biosynthesis; D005492:Folic Acid / Q000096:biosynthesis; D005815:Genetic Code; D006801:Humans; D007275:Injections, Intravenous; D009698:Nucleoproteins / Q000037:antagonists & inhibitors; D010429:Pentoses / Q000096:biosynthesis; D011685:Purine Nucleotides / Q000096:biosynthesis; D011743:Pyrimidines / Q000096:biosynthesis; D012313:RNA / Q000096:biosynthesis; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D009698:Nucleoproteins; D010429:Pentoses; D011685:Purine Nucleotides; D011743:Pyrimidines; D014747:Vinblastine; D012313:RNA; D004247:DNA; D005492:Folic Acid; D001215:Asparaginase
Bases moleculares y farmacológicas de la quimioterapia antineoplásica.